AIC
GTHX

Ameritas Investment Company’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Ameritas Investment Company’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,305
Closed -$30K – 1564
2019
Q3 		$30K Buy
+1,305
New +$41.1K 0.01% 809

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Ameritas Investment Company's GTHX Position: Q4 2019 in Review

Ameritas Investment Company sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2019, closing a stake of 1,305 shares — an estimated $30K sold.

Ameritas Investment Company first reported a position in GTHX in Q3 2019 and held it in 1 quarter. The position peaked at $30K in Q3 2019. 98 funds tracked by Wall St. Rank hold GTHX as of Q4 2019.

  • Ameritas Investment Company reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 1,305 G1 Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $30K.
  • Ameritas Investment Company first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Ameritas Investment Company's G1 Therapeutics, Inc. Common Stock position peaked at $30K in Q3 2019.
  • 98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Ameritas Investment Company's 13F filing for Q4 2019, filed 18 Feb 2020.